home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Shareware Overload Trio 2
/
Shareware Overload Trio Volume 2 (Chestnut CD-ROM).ISO
/
dir26
/
med9408c.zip
/
M9480560.TXT
< prev
next >
Wrap
Text File
|
1994-08-20
|
2KB
|
38 lines
Document 0560
DOCN M9480560
TI Comparative contraceptive efficacy of the female condom and other
barrier methods.
DT 9410
AU Trussell J; Sturgen K; Strickler J; Dominik R; Woodrow Wilson School of
Public and International Affairs,; Princeton University, N.J.
SO Fam Plann Perspect. 1994 Mar-Apr;26(2):66-72. Unique Identifier :
AIDSLINE MED/94307358
AB Because the research design for the clinical trial establishing the
contraceptive efficacy of the female condom--a six-month life-table
probability of failure of 15% (12% in the United States vs. 22% in Latin
America)--did not include randomization with another method of
contraception, no definite conclusion about its comparative efficacy is
possible. Comparisons using other female barrier methods as historical
controls, however, provide evidence that, among women in the United
States, the contraceptive efficacy of the female condom during typical
use is not significantly different from that of the diaphragm, the
sponge or the cervical cap. The six-month probability of failure during
perfect use of the female condom is 2.6% among U.S. women, similar to
rates for the diaphragm and the cervical cap but significantly lower
than that for the sponge. Meaningful comparisons with the male condom
are not possible because of the lack of data from carefully controlled
prospective clinical trials. Extrapolations from the results on
contraceptive efficacy suggest that perfect use of the female condom may
reduce the annual risk of acquiring the human immunodeficiency virus by
more than 90% among women who have intercourse twice weekly with an
infected male.
DE Clinical Trials Comparative Study Condoms/*STANDARDS Contraceptive
Devices, Female/*STANDARDS Female Human HIV
Infections/EPIDEMIOLOGY/PREVENTION & CONTROL/TRANSMISSION Latin America
Life Tables Male Patient Compliance Research Design Risk Factors
United States JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).